Xiaofeng Li

1.2k total citations
51 papers, 890 citations indexed

About

Xiaofeng Li is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Xiaofeng Li has authored 51 papers receiving a total of 890 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Radiology, Nuclear Medicine and Imaging, 15 papers in Pulmonary and Respiratory Medicine and 14 papers in Molecular Biology. Recurrent topics in Xiaofeng Li's work include Radiomics and Machine Learning in Medical Imaging (11 papers), Lung Cancer Diagnosis and Treatment (9 papers) and Nanoplatforms for cancer theranostics (8 papers). Xiaofeng Li is often cited by papers focused on Radiomics and Machine Learning in Medical Imaging (11 papers), Lung Cancer Diagnosis and Treatment (9 papers) and Nanoplatforms for cancer theranostics (8 papers). Xiaofeng Li collaborates with scholars based in China, United States and Australia. Xiaofeng Li's co-authors include Wengui Xu, Dong Dai, Jianjing Liu, Lei Zhu, Guotao Yin, Xiaozhou Yu, Xiuyu Song, Yiwen Chen, Rui Tan and Wenjuan Ma and has published in prestigious journals such as Advanced Materials, SHILAP Revista de lepidopterología and Advanced Functional Materials.

In The Last Decade

Xiaofeng Li

48 papers receiving 883 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaofeng Li China 19 262 208 205 199 181 51 890
Maureen Aliru United States 10 192 0.7× 117 0.6× 206 1.0× 161 0.8× 125 0.7× 20 693
Luofu Wang China 19 337 1.3× 109 0.5× 355 1.7× 180 0.9× 125 0.7× 44 907
Bingxin Gu China 14 173 0.7× 157 0.8× 85 0.4× 94 0.5× 273 1.5× 47 673
Qingjie Ma China 13 253 1.0× 135 0.6× 175 0.9× 68 0.3× 110 0.6× 26 678
Yolanda E. Hartman United States 14 586 2.2× 148 0.7× 205 1.0× 293 1.5× 209 1.2× 23 1.1k
Dennis Doleschel Germany 11 257 1.0× 101 0.5× 148 0.7× 58 0.3× 169 0.9× 17 678
Mary‐Keara Boss United States 11 126 0.5× 98 0.5× 142 0.7× 205 1.0× 161 0.9× 41 616
Zengfu Zhang China 10 108 0.4× 101 0.5× 157 0.8× 159 0.8× 251 1.4× 22 675

Countries citing papers authored by Xiaofeng Li

Since Specialization
Citations

This map shows the geographic impact of Xiaofeng Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaofeng Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaofeng Li more than expected).

Fields of papers citing papers by Xiaofeng Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaofeng Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaofeng Li. The network helps show where Xiaofeng Li may publish in the future.

Co-authorship network of co-authors of Xiaofeng Li

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaofeng Li. A scholar is included among the top collaborators of Xiaofeng Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaofeng Li. Xiaofeng Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
4.
Zhu, Sai, Xin Chen, Xiaofeng Li, et al.. (2024). N6-Methyladenosine modification of circDcbld2 in Kupffer cells promotes hepatic fibrosis via targeting miR-144-3p/Et-1 axis. Acta Pharmaceutica Sinica B. 15(1). 296–313. 4 indexed citations
5.
Li, Xiaofeng, Pengyu Huang, Yang Li, et al.. (2024). In situ Blending For Co‐Deposition of Electron Transport and Perovskite Layers Enables Over 24% Efficiency Stable Conventional Solar Cells. Advanced Materials. 36(36). e2407349–e2407349. 18 indexed citations
6.
Li, Xiaofeng, Xiaofang Chen, Yanan Li, et al.. (2023). Fe/MOF based platform for NIR laser induced efficient PDT/PTT of cancer. Frontiers in Bioengineering and Biotechnology. 11. 1156079–1156079. 21 indexed citations
7.
Doh, Shu Ing, et al.. (2023). Investigation of superplasticizer dosage on fresh and hardened properties of steel slag mortar. AIP conference proceedings. 2747. 20012–20012. 3 indexed citations
8.
Li, Xiaofeng, Yiwen Chen, Ting Wang, et al.. (2023). GPR81-mediated reprogramming of glucose metabolism contributes to the immune landscape in breast cancer. Discover Oncology. 14(1). 140–140. 7 indexed citations
9.
Bai, Chen, et al.. (2023). Design of a nanozyme-based magnetic nanoplatform to enhance photodynamic therapy and immunotherapy. Journal of Pharmaceutical Analysis. 14(9). 100928–100928. 6 indexed citations
10.
Liu, Weishuai, Xiaozhou Yu, Yixing Feng, et al.. (2022). CD73, a Promising Therapeutic Target of Diclofenac, Promotes Metastasis of Pancreatic Cancer through a Nucleotidase Independent Mechanism. Advanced Science. 10(6). e2206335–e2206335. 22 indexed citations
11.
Yu, Xiaozhou, Weishuai Liu, Ziyang Wang, et al.. (2021). CD73 induces gemcitabine resistance in pancreatic ductal adenocarcinoma: A promising target with non-canonical mechanisms. Cancer Letters. 519. 289–303. 25 indexed citations
12.
Qi, Lisha, Dandan Chen, Chunxiang Li, et al.. (2021). Diagnosis of Ovarian Neoplasms Using Nomogram in Combination With Ultrasound Image-Based Radiomics Signature and Clinical Factors. Frontiers in Genetics. 12. 753948–753948. 26 indexed citations
13.
Li, Xiaofeng, Guotao Yin, Wei Ji, et al.. (2020). <p><sup>18</sup>F-FHBG PET-CT Reporter Gene Imaging of Adoptive CIK Cell Transfer Immunotherapy for Breast Cancer in a Mouse Model</p>. OncoTargets and Therapy. Volume 13. 11659–11668. 1 indexed citations
14.
Zhu, Lei, Xiaofeng Li, Jian Wang, et al.. (2020). Value of metabolic parameters in distinguishing primary mediastinal lymphomas from thymic epithelial tumors. Cancer Biology and Medicine. 17(2). 468–477. 10 indexed citations
15.
Chen, Wei, Xiaofeng Li, Lei Zhu, et al.. (2017). Preclinical and clinical applications of specific molecular imaging for HER2-positive breast cancer. Cancer Biology and Medicine. 14(3). 271–271. 15 indexed citations
16.
Li, Xiaofeng, Dong Dai, Xiuyu Song, et al.. (2017). A different representation of natural T cells and natural killer cells between tumor-infiltrating and periphery lymphocytes in human hepatocellular carcinoma. Oncology Letters. 13(5). 3291–3298. 10 indexed citations
17.
Yu, Xiaozhou, Xiaofeng Li, Xiuyu Song, et al.. (2016). Advantages and disadvantages of F-18 fluorodeoxyglucose positron emission tomography/computed tomography in carcinoma of unknown primary. Oncology Letters. 12(5). 3785–3792. 18 indexed citations
18.
Dong, Meng, Guangjun Jiao, Haichun Liu, et al.. (2016). Biological Silicon Stimulates Collagen Type 1 and Osteocalcin Synthesis in Human Osteoblast-Like Cells Through the BMP-2/Smad/RUNX2 Signaling Pathway. Biological Trace Element Research. 173(2). 306–315. 82 indexed citations
19.
Dai, Dong, Xiaofeng Li, Jian Wang, et al.. (2015). Predictive efficacy of 11C‐PD153035 PET imaging for EGFR–tyrosine kinase inhibitor sensitivity in non‐small cell lung cancer patients. International Journal of Cancer. 138(4). 1003–1012. 20 indexed citations
20.
Li, Xiaofeng, Dong Dai, Xiuyu Song, et al.. (2014). A meta-analysis of cytokine-induced killer cells therapy in combination with minimally invasive treatment for hepatocellular carcinoma. Clinics and Research in Hepatology and Gastroenterology. 38(5). 583–591. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maureen Aliru Breakdown of academic impact, for papers by Luofu Wang Breakdown of academic impact, for papers by Bingxin Gu Breakdown of academic impact, for papers by Qingjie Ma Breakdown of academic impact, for papers by Yolanda E. Hartman Breakdown of academic impact, for papers by Dennis Doleschel Breakdown of academic impact, for papers by Mary‐Keara Boss Breakdown of academic impact, for papers by Zengfu Zhang
Rankless by CCL
2026